Ramiya et al., 1996 - Google Patents
Antigen based therapies to prevent diabetes in NOD miceRamiya et al., 1996
View PDF- Document ID
- 15088047658080275678
- Author
- Ramiya V
- Shang X
- Pharis P
- Wasserfall C
- Stabler T
- Muir A
- Schatz D
- Maclaren N
- Publication year
- Publication venue
- Journal of autoimmunity
External Links
Snippet
Interventional approaches that have been successful in delaying insulin-dependent diabetes mellitus (IDDM) using antigen-based immunotherapies include parenteral immunization. It has potential for clinical application provided that effective adjuvants …
- 206010012601 Diabetes mellitus 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ramiya et al. | Antigen based therapies to prevent diabetes in NOD mice | |
| JP3165148B2 (en) | Diagnosis and treatment of insulin-dependent diabetes | |
| Harrison | Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited | |
| Elias et al. | Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277 | |
| JP2635444B2 (en) | Treatment of autoimmune diseases by oral administration of autoantibodies | |
| AU2008339093B2 (en) | Compositions and methods for treatment of autoimmune and allergic diseases | |
| AU737287B2 (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | |
| JP5346414B2 (en) | Novel compositions and methods for treating autoimmune and allergic diseases | |
| US5780034A (en) | Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents | |
| JP3420245B2 (en) | Peptide p277 analog and pharmaceutical composition for treating or diagnosing diabetes containing the same | |
| US20060089302A1 (en) | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases | |
| US6022697A (en) | Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus | |
| US5578303A (en) | Diagnosis and treatment of insulin dependent diabetes mellitus | |
| Ramiya et al. | Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice | |
| Ramiya et al. | Immunization therapies in the prevention of diabetes | |
| Charlton et al. | Th1 unresponsiveness can be infectious for unrelated antigens | |
| WO1999034817A1 (en) | Agent for treating allergic or hypersensitivity condition | |
| WO2011150235A1 (en) | Methods and reagents for treating autoimmune disorders and/or graft rejection | |
| Gearon et al. | Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus | |
| Kaushansky et al. | OSP/claudin‐11‐induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179–207 | |
| WO1999053945A1 (en) | Neuron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration | |
| Hurtenbach et al. | Type I diabetes in NOD mice is not associated with insulin-specific, autoreactive T cells | |
| Garg et al. | Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity | |
| Soldera et al. | Selective down‐regulation of Th2 immune responses following treatment with antigen‐coupled splenocytes | |
| Bungiro Jr et al. | Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge |